drugset / Trial / NCT00892723
A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study was to determine the safety of AZX100 Drug Product and to determine whether it was effective in preventing or reducing re-growth of surgically removed keloid scars.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-09
- Completion
- 2010-09
Outcome
Missed primary endpoint
registry PSAS Results for Placebo vs PSAS Results for 0.3 mg AZX100; p = 0.87; Wilcoxon (rank sum) NCT00892723 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZX100 | Unknown | 0.3 mg | Other |
| Subject | AZX100 | Unknown | 10 mg | Other |